Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Epilepsia ; 52(6): 1150-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21671925

ABSTRACT

PURPOSE: To pool data from four published case-control studies of sudden unexpected death in epilepsy (SUDEP) with live controls, to increase the power to determine risk factors. METHODS: Case-control studies from the United States, Sweden, Scotland, and England were combined. SUDEP was defined as (1) a history of epilepsy (>1 epileptic seizure during a period of < 5 years); (2) death occurring suddenly; (3) death unexpected (i.e., no life-threatening illness); and (4) death remained unexplained after all investigative efforts, including autopsy. Definite SUDEP required all criteria. Logistic regression analyses adjusted for study. Further analysis simultaneously adjusted for study, age at death, gender, and duration of epilepsy. KEY FINDINGS: Of the risk factors that could be analyzed across some or all studies, those that were statistically significant were increased frequency of generalized tonic-clonic seizures (GTCS), use of polytherapy, duration of epilepsy, young age at onset, gender, symptomatic etiology, and lamotrigine therapy. Results persisted when epilepsy onset was younger than 16 years and when it was 16 years or older. In univariate analysis, lamotrigine therapy was associated with significantly increased risk for SUDEP among individuals with idiopathic generalized epilepsy. SIGNIFICANCE: This analysis refines the identification of people with epilepsy that are at particular risk of SUDEP. The emerging profile indicates that people with early onset refractory symptomatic epilepsy with frequent GTCS and antiepileptic drug (AED) polytherapy are at higher risk. The results suggest that reduction of the number of GTCS is a priority, of more importance than reducing the number of AEDs. The role of AEDs and other treatment should be analyzed further in future studies.


Subject(s)
Death, Sudden/epidemiology , Epilepsy/mortality , Adolescent , Adult , Aged , Anticonvulsants/therapeutic use , Case-Control Studies , Cohort Studies , England/epidemiology , Epilepsy/complications , Epilepsy/drug therapy , Female , Humans , Male , Middle Aged , Risk Factors , Scotland/epidemiology , Sweden/epidemiology , United States/epidemiology , Young Adult
3.
Epilepsia ; 52(5): 957-64, 2011 May.
Article in English | MEDLINE | ID: mdl-21320113

ABSTRACT

PURPOSE: To determine the persistence of disparities in health care use and outcomes in socioeconomically diverse populations of epilepsy patients. METHODS: We followed patients for a year at one clinic in Houston and two in New York City that serve predominantly low-income, minority, Medicaid-insured, or uninsured patients, and a fourth clinic in Houston that serves a more balanced racial/ethnic and higher socioeconomic status (SES) population. We interviewed the patients several times regarding health care use, seizures, side effects, and outcomes, and examined differences between the patients at the three low-SES clinics and the patients at the high-SES clinic. KEY FINDINGS: After controlling for patients' age, gender, race/ethnicity, marital status, seizures, and side effects we found that low SES patients had consistently higher use of the hospital emergency room and more visits to a general practitioner. Hospitalizations were also consistently higher but the differences were not significant in most periods. Neurologist visits were relatively similar. Patients at the low SES sites also had a greater likelihood of having uncontrolled seizures, drug-related side effects, to be stigmatized, and have a lower overall quality of life throughout the study period. SIGNIFICANCE: These findings suggest the persistence of SES-related disparities in health care use and outcomes among patients with epilepsy who are receiving regular care.


Subject(s)
Epilepsy/therapy , Health Services/statistics & numerical data , Healthcare Disparities , Social Class , Adolescent , Adult , Aged , Child , Emergency Service, Hospital/statistics & numerical data , Female , General Practice/statistics & numerical data , Health Care Surveys , Health Services Accessibility , Humans , Male , Medically Uninsured , Middle Aged , Minority Groups , Office Visits/statistics & numerical data , Socioeconomic Factors , Surveys and Questionnaires , Treatment Outcome
4.
Epilepsia ; 50(5): 1040-50, 2009 May.
Article in English | MEDLINE | ID: mdl-19054413

ABSTRACT

PURPOSE: The purpose of this study was to identify sociodemographic disparities in health care use among epilepsy patients receiving care at different sites and the extent to which the disparities persisted after adjusting for patient characteristics and site of care. METHODS: Three months of health care use data were obtained from baseline interviews of approximately 560 patients at four sites. One-half of the patients were from a Houston site and two NYC sites that serve predominantly low-income, minority, publicly insured, or uninsured patients. The other half were at the remaining site in Houston that serves a more balanced racial/ethnic and higher sociodemographic population. Differences in general and specialist visits, hospital emergency room (ER) care, and hospitalizations were associated with race/ethnicity, income, and coverage. Logistic regression was used to assess the extent to which the differences persisted when adjusting for individual patient characteristics and site of care. RESULTS: Compared to whites, blacks and Hispanics had higher rates of generalist visits [odds ratio (OR) = 5.3 and 4.9, p < 0.05), ER care (OR = 3.1 and 2.9, p < 0.05) and hospitalizations (OR = 5.4 and 6.2, p < 0.05), and lower rates of specialist visits (OR = 0.3 and 0.4, p < 0.05). A similar pattern was found related to patient income and coverage. The magnitude and significance of the disparities persisted when adjusting for individual characteristics but decreased substantially or were eliminated when site of care was added to the model. DISCUSSION: There are sociodemographic disparities in health care for people with epilepsy that are largely explained by differences in where patients receive care.


Subject(s)
Community Mental Health Services/statistics & numerical data , Epilepsy , Health Care Surveys , Healthcare Disparities/statistics & numerical data , Confidence Intervals , Epilepsy/epidemiology , Epilepsy/therapy , Ethnicity/statistics & numerical data , Female , Health Services Accessibility/statistics & numerical data , Humans , Interviews as Topic , Male , New York/epidemiology , Odds Ratio , Retrospective Studies , Socioeconomic Factors , Texas/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...